US EditionITC judge says Apple Watch's redesigned blood oxygen feature doesn't infringe Masimo patents
Apple’s redesign moves blood oxygen processing to iPhone, avoiding patent infringement while the original feature remains banned under a 2023 ITC exclusion order.
9 Articles
9 Articles
Apple Watch Avoids U.S. Import Ban: ITC Rules Current Apple Products No Patent Infringement. Apple has temporarily escaped the crisis of a renewed import ban on its smartwatch, the Apple Watch, in the United States. An administrative judge at the U.S. International Trade Commission (ITC) ruled that the Apple Watch currently on sale infringes on medical technology firm Masimo's blood oxygen measurement patents.
Apple changed its watches to round up an import ban issued by the United States International Trade Commission in 2023
Apple Watch Blood Oxygen Measurement Trick Does Not Infringe On Patents Owned By Masimo, Rules A US Tribunal
Multiple iterations of the Apple Watch are not currently under a threat of an import ban into the United States, as per a new ruling by the US-based International Trade Commission (ITC) in what appears to be a satisfactory end - for now - on the part of Apple to a long-standing patent dispute with the medical-monitoring company, Masimo. The blood oxygen measurement workaround that the Apple Watch uses does not infringe on the patents held by Mas…
Redesigned Apple Watches Don’t Infringe Masimo Patents, ITC Juge Finds - Orange County Business Journal
A U.S. International Trade Commission (ITC) judge has found that Apple’s redesigned smart watches do not infringe on Masimo’s patents in a preliminary ruling, Reuters reported. The full commission will now review the judge’s decision for approval, according to Reuters. The preliminary ITC ruling comes three years after the ITC issued an import ban on Apple’s Series 9 and Ultra 2 watches in 2023, resulting in Apple appealing the decision and inte…
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
